A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Marc Ferrell(Cleveland Clinic Lerner College of Medicine), Stanley L. Hazen(Cleveland Clinic), Arash Haghikia(German Centre for Cardiovascular Research), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Tomáš Čajka(Czech Academy of Sciences), W.H. Wilson Tang(Cleveland Clinic), Zeneng Wang(Cleveland Clinic), Jaana Hartiala(University of Southern California), Marco Witkowski(Cleveland Clinic), James T. Anderson(EpiCypher (United States)), Joseph A. DiDonato(Cleveland Clinic), Maximilian König(Charité - Universitätsmedizin Berlin), Ilja Demuth(Charité - Universitätsmedizin Berlin), Ulf Landmesser(Deutsches Herzzentrum der Charité), Hooman Allayee(Broad Institute), Oliver Fiehn(University of California, Davis), Naseer Sangwan(Argonne National Laboratory), Xinmin S. Li(Cleveland Clinic), James R. Hilser(University of Southern California)
Cited by 124
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
|Nature Methods|2015|3.4k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k